267 related articles for article (PubMed ID: 19936192)
1. Morphological and molecular changes of the myocardium after left ventricular mechanical support.
Baba HA; Wohlschlaeger J
Curr Cardiol Rev; 2008 Aug; 4(3):157-69. PubMed ID: 19936192
[TBL] [Abstract][Full Text] [Related]
2. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
[TBL] [Abstract][Full Text] [Related]
3. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support.
Rodrigue-Way A; Burkhoff D; Geesaman BJ; Golden S; Xu J; Pollman MJ; Donoghue M; Jeyaseelan R; Houser S; Breitbart RE; Marks A; Acton S
J Heart Lung Transplant; 2005 Jan; 24(1):73-80. PubMed ID: 15653383
[TBL] [Abstract][Full Text] [Related]
4. Molecular changes after left ventricular assist device support for heart failure.
Birks EJ
Circ Res; 2013 Aug; 113(6):777-91. PubMed ID: 23989719
[TBL] [Abstract][Full Text] [Related]
5. [Left ventricular assist devices (LVAD): optional treatment alternative to cardiac transplantation?].
Wohlschlaeger J; Kawaguchi N; Levkau B; Schmid C; Scheld HH; Baba HA
Verh Dtsch Ges Pathol; 2004; 88():113-21. PubMed ID: 16892541
[TBL] [Abstract][Full Text] [Related]
6. [Congestive heart failure: reverse cardiac remodeling mediated by left ventricular assist devices].
Wohlschläger J; Milting H; Stypmann J; Hager T; Schmid C; Levkau B; Baba HA
Pathologe; 2012 May; 33(3):175-82. PubMed ID: 22576594
[TBL] [Abstract][Full Text] [Related]
7. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
Klotz S; Jan Danser AH; Burkhoff D
Prog Biophys Mol Biol; 2008; 97(2-3):479-96. PubMed ID: 18394685
[TBL] [Abstract][Full Text] [Related]
8. Heterotopic transplantation of the failing rat heart as a model of left ventricular mechanical unloading toward recovery.
Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Ikeda T; Nishimura K; Komeda M
ASAIO J; 2005; 51(1):116-20. PubMed ID: 15745145
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: observations made after implantation of left ventricular assist device.
Francis GS; Anwar F; Bank AJ; Kubo SH; Jessurun J
J Card Fail; 1999 Dec; 5(4):308-15. PubMed ID: 10634672
[TBL] [Abstract][Full Text] [Related]
10. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling.
Barbone A; Holmes JW; Heerdt PM; The' AH; Naka Y; Joshi N; Daines M; Marks AR; Oz MC; Burkhoff D
Circulation; 2001 Aug; 104(6):670-5. PubMed ID: 11489773
[TBL] [Abstract][Full Text] [Related]
11. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional patterns of reverse remodeling with left ventricular assist devices: a consistent signature.
Ton VK; Vunjak-Novakovic G; Topkara VK
Expert Rev Med Devices; 2016 Nov; 13(11):1029-1034. PubMed ID: 27685648
[TBL] [Abstract][Full Text] [Related]
13. Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study.
Patel SR; Saeed O; Murthy S; Bhatia V; Shin JJ; Wang D; Negassa A; Pullman J; Goldstein DJ; Maybaum S
J Heart Lung Transplant; 2013 Mar; 32(3):305-12. PubMed ID: 23415314
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategies for myocardial recovery in heart failure.
Lenneman AJ; Birks EJ
Curr Treat Options Cardiovasc Med; 2014 Mar; 16(3):287. PubMed ID: 24492922
[TBL] [Abstract][Full Text] [Related]
15. Regression of cellular hypertrophy after left ventricular assist device support.
Zafeiridis A; Jeevanandam V; Houser SR; Margulies KB
Circulation; 1998 Aug; 98(7):656-62. PubMed ID: 9715858
[TBL] [Abstract][Full Text] [Related]
16. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments.
Margulies KB
J Card Fail; 2002 Dec; 8(6 Suppl):S500-5. PubMed ID: 12555165
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte survivin protein expression is associated with cell size and DNA content in the failing human heart and is reversibly regulated after ventricular unloading.
Wohlschlaeger J; Meier B; Schmitz KJ; Takeda A; Takeda N; Vahlhaus C; Levkau B; Stypmann J; Schmid C; Schmid KW; Baba HA
J Heart Lung Transplant; 2010 Nov; 29(11):1286-92. PubMed ID: 20851637
[TBL] [Abstract][Full Text] [Related]
18. Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism.
Baba HA; Stypmann J; Grabellus F; Kirchhof P; Sokoll A; Schäfers M; Takeda A; Wilhelm MJ; Scheld HH; Takeda N; Breithardt G; Levkau B
Cardiovasc Res; 2003 Aug; 59(2):390-9. PubMed ID: 12909322
[TBL] [Abstract][Full Text] [Related]
19. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
Klotz S; Naka Y; Oz MC; Burkhoff D
J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular assist device-induced molecular changes in the failing myocardium.
Soppa GK; Barton PJ; Terracciano CM; Yacoub MH
Curr Opin Cardiol; 2008 May; 23(3):206-18. PubMed ID: 18382208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
